The connection between testosterone and prostate cancer has been a confusing one, and often paradoxical. The latest article by BrinkZone.com author science writer Monica Mollica may explain why and is a must read on the topic:
Testosterone and Prostate Cancer – Bye Androgen Hypothesis, Welcome Saturation Model
Summary/take home for those who don't wanna read the science jargon:
"The long-held belief that prostate cancer risk is related to high testosterone levels, aka the Androgen Hypothesis, is not supported by clinical data. The Saturation Model and paradigm change that it brings to old inaccurate reasoning is that testosterone has a finite ability to stimulate prostate cancer growth.
The saturation model explains the paradoxical observations that prostate tissue is sensitive to changes in testosterone levels at low concentrations, but becomes insensitive to changes in testosterone levels at higher levels. Men with high testosterone levels are not at increased risk of developing prostate cancer, low testosterone levels provide no protection against the development of prostate cancer, and some men with untreated prostate cancer have received testosterone therapy without evidence of prostate cancer progression.Current evidence shows that maximal testosterone-stimulated prostate cancer growth is achieved at low sub-optimal testosterone levels."
Testosterone and Prostate Cancer – Bye Androgen Hypothesis, Welcome Saturation Model
Summary/take home for those who don't wanna read the science jargon:
"The long-held belief that prostate cancer risk is related to high testosterone levels, aka the Androgen Hypothesis, is not supported by clinical data. The Saturation Model and paradigm change that it brings to old inaccurate reasoning is that testosterone has a finite ability to stimulate prostate cancer growth.
The saturation model explains the paradoxical observations that prostate tissue is sensitive to changes in testosterone levels at low concentrations, but becomes insensitive to changes in testosterone levels at higher levels. Men with high testosterone levels are not at increased risk of developing prostate cancer, low testosterone levels provide no protection against the development of prostate cancer, and some men with untreated prostate cancer have received testosterone therapy without evidence of prostate cancer progression.Current evidence shows that maximal testosterone-stimulated prostate cancer growth is achieved at low sub-optimal testosterone levels."
Comment